TY - JOUR
T1 - Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
AU - Flavahan, William A.
AU - Wu, Qiulian
AU - Hitomi, Masahiro
AU - Rahim, Nasiha
AU - Kim, Youngmi
AU - Sloan, Andrew E.
AU - Weil, Robert J.
AU - Nakano, Ichiro
AU - Sarkaria, Jann N.
AU - Stringer, Brett W.
AU - Day, Bryan W.
AU - Li, Meizhang
AU - Lathia, Justin D.
AU - Rich, Jeremy N.
AU - Hjelmeland, Anita B.
PY - 2013/10
Y1 - 2013/10
N2 - Like all cancers, brain tumors require a continuous source of energy and molecular resources for new cell production. In normal brain, glucose is an essential neuronal fuel, but the blood-brain barrier limits its delivery. We now report that nutrient restriction contributes to tumor progression by enriching for brain tumor initiating cells (BTICs) owing to preferential BTIC survival and to adaptation of non-BTICs through acquisition of BTIC features. BTICs outcompete for glucose uptake by co-opting the high affinity neuronal glucose transporter, type 3 (Glut3, SLC2A3). BTICs preferentially express Glut3, and targeting Glut3 inhibits BTIC growth and tumorigenic potential. Glut3, but not Glut1, correlates with poor survival in brain tumors and other cancers; thus, tumor initiating cells may extract nutrients with high affinity. As altered metabolism represents a cancer hallmark, metabolic reprogramming may maintain the tumor hierarchy and portend poor prognosis.
AB - Like all cancers, brain tumors require a continuous source of energy and molecular resources for new cell production. In normal brain, glucose is an essential neuronal fuel, but the blood-brain barrier limits its delivery. We now report that nutrient restriction contributes to tumor progression by enriching for brain tumor initiating cells (BTICs) owing to preferential BTIC survival and to adaptation of non-BTICs through acquisition of BTIC features. BTICs outcompete for glucose uptake by co-opting the high affinity neuronal glucose transporter, type 3 (Glut3, SLC2A3). BTICs preferentially express Glut3, and targeting Glut3 inhibits BTIC growth and tumorigenic potential. Glut3, but not Glut1, correlates with poor survival in brain tumors and other cancers; thus, tumor initiating cells may extract nutrients with high affinity. As altered metabolism represents a cancer hallmark, metabolic reprogramming may maintain the tumor hierarchy and portend poor prognosis.
UR - http://www.scopus.com/inward/record.url?scp=84884893986&partnerID=8YFLogxK
U2 - 10.1038/nn.3510
DO - 10.1038/nn.3510
M3 - Article
C2 - 23995067
AN - SCOPUS:84884893986
SN - 1097-6256
VL - 16
SP - 1373
EP - 1382
JO - NATURE NEUROSCIENCE
JF - NATURE NEUROSCIENCE
IS - 10
ER -